共 50 条
[1]
Sivamani RK(2010)Biological therapy of psoriasis Indian J Dermatol. 55 161-70
[2]
Correa G(2020)Global burden of psoriasis—comparison of regional and global epidemiology, 1990 to 2017 Int J Dermatol. 59 566-71
[3]
Ono Y(2014)Psoriasis prevalence among adults in the United States J Am Acad Dermatol 70 512-516
[4]
Bowen MP(2019)Trends in the prevalence and incidence of psoriasis and psoriatic arthritis in Ontario, Canada: a population-based study Arthritis Care Res (Hoboken) 71 1084-1091
[5]
Raychaudhuri SP(2016)2016 Addendum to the Canadian guidelines for the management of plaque psoriasis 2009 J Cutan Med Surg 20 375-431
[6]
Maverakis E(2018)Psoriasis, cardiovascular events, and biologics: lights and shadows Front Immunol 9 1668-158
[7]
AlQassimi S(2013)Psoriasis CMAJ 185 E174-566
[8]
AlBrashdi S(2018)Safety and tolerability of adalimumab for the treatment of psoriasis: a review summarizing 15 years of real-life experience Ther Adv Chronic Dis 9 147-381
[9]
Galadari H(2008)Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) Br J Dermatol 158 558-1559
[10]
Hashim MJ(2017)Long-term safety and effectiveness of adalimumab for moderate to severe psoriasis: results from 7-year interim analysis of the ESPRIT registry Dermatol Ther (Heidelb) 7 365-1166